08/20/2024
7:45 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 4/A | |
08/20/2024
7:46 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4/A | |
08/20/2024
7:46 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 4/A | |
08/19/2024
7:59 PM | Actuate Therapeutics (Subject)
BIOS Fund I, LP (Filed by)
| Form SC 13D | |
08/19/2024
4:25 PM | Actuate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
8:12 PM | Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:46 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/14/2024
7:49 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:51 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:54 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:56 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:44 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:48 PM | Actuate Therapeutics (Issuer)
Bios 2024 Co-Invest, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
6:23 PM | Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
6:23 PM | Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
6:25 PM | Actuate Therapeutics (Issuer)
Sawhney Roger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:26 PM | Actuate Therapeutics (Issuer)
RONNEBERG AMY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:27 PM | Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:28 PM | Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:29 PM | Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:30 PM | Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
4:14 PM | Actuate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/14/2024
3:37 PM | Actuate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
2:11 PM | Actuate Therapeutics (Filer)
| Form POS EX | |
08/13/2024
1:50 PM | Actuate Therapeutics (Filer)
| Form 424B4 | |
08/12/2024
11:15 PM | Actuate Therapeutics (Filer)
| Form EFFECT | |
08/12/2024
8:45 PM | Actuate Therapeutics (Issuer)
Keyes Jason A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:46 PM | Actuate Therapeutics (Issuer)
LYTLE PAUL J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:47 PM | Actuate Therapeutics (Issuer)
Mazar Andrew Paul (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:48 PM | Actuate Therapeutics (Issuer)
SCHMITT DANIEL M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
8:49 PM | Actuate Therapeutics (Issuer)
Zabrowski Dan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:57 PM | Actuate Therapeutics (Issuer)
Kairos SPV Fund LLC (Reporting)
Kairos Venture Opportunities I, L.P. (Reporting)
Kairos Venture Partners II, L.P. (Reporting)
Kairos-Actuate SPV, L.P. (Reporting)
THOMSON TODD S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:29 PM | Actuate Therapeutics (Issuer)
Bios Equity Partners II, LP (Reporting)
Bios Equity Partners, LP (Reporting)
BIOS Fund I QP, LP (Reporting)
BIOS Fund I, LP (Reporting)
BIOS Fund II NT, LP (Reporting)
BIOS Fund II QP, LP (Reporting)
BIOS Fund II, LP (Reporting)
Cavu Advisors, LLC (Reporting)
Cavu Management, LP (Reporting)
Kreis Leslie W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:30 PM | Actuate Therapeutics (Issuer)
BIOS Actuate Co-Invest I, LP (Reporting)
BIOS Actuate Co-Invest II, LP (Reporting)
Bios Actuate Co-Invest III, LP (Reporting)
BIOS Advisors GP, LLC (Reporting)
BIOS Capital Management, LP (Reporting)
BIOS Equity Partners III, LP (Reporting)
BIOS Fund III NT, LP (Reporting)
BIOS Fund III QP, LP (Reporting)
BIOS Fund III, LP (Reporting)
Fletcher Aaron G.L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
5:30 PM | Actuate Therapeutics (Issuer)
Bios Clinical Opportunity Fund, LP (Reporting)
Bios Equity COF, LP (Reporting)
BP Directors, LP (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/12/2024
12:35 PM | Actuate Therapeutics (Filer)
| Form CERT | |
08/12/2024
10:58 AM | Actuate Therapeutics (Filer)
| Form 8-A12B/A | |
07/23/2024
5:01 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
07/23/2024
5:01 AM | Actuate Therapeutics (Subject)
| Form FWP | |
07/19/2024
7:01 AM | Actuate Therapeutics (Subject)
| Form FWP | |
07/19/2024
6:58 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
My big AI project… (Ad) On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron.
This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016. Just click here to register. |
07/16/2024
1:41 PM | Actuate Therapeutics (Filer)
| Form S-1/A | |
06/21/2024
4:12 PM | Actuate Therapeutics (Subject)
| Form FWP | |
06/21/2024
11:47 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
06/20/2024
8:40 AM | Actuate Therapeutics (Filer)
| Form 8-A12B | |
06/11/2024
6:01 AM | Actuate Therapeutics (Filer)
| Form S-1/A | |
06/11/2024
6:15 AM | Actuate Therapeutics (Subject)
| Form FWP | |
03/06/2024
11:07 AM | Actuate Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
